.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Chinese Patent Office
Mallinckrodt
Covington
Daiichi Sankyo
Citi
Fish and Richardson
Boehringer Ingelheim
Cerilliant
Julphar

Generated: December 14, 2017

DrugPatentWatch Database Preview

Nifedipine - Generic Drug Details

« Back to Dashboard

What are the generic sources for nifedipine and what is the scope of nifedipine freedom to operate?

Nifedipine
is the generic ingredient in six branded drugs marketed by Bayer Pharms, Actavis Elizabeth, Chase Labs Nj, Heritage Pharma, Intergel Pharm, Teva, Validus Pharms, Pfizer, Alvogen, Watson Labs, Watson Labs Teva, Martec Usa Llc, Mylan, Mylan Labs Ltd, Novast Labs Ltd, Osmotica Pharm Us, Par Pharm, Twi Pharms Inc, and Valeant Pharms North, and is included in twenty-eight NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-nine drug master file entries for nifedipine. Fifty-three suppliers are listed for this compound.

Pharmacology for nifedipine

Medical Subject Heading (MeSH) Categories for nifedipine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Validus PharmsNIFEDIPINEnifedipineCAPSULE;ORAL074045-001Apr 30, 1992ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
AlvogenADALAT CCnifedipineTABLET, EXTENDED RELEASE;ORAL020198-003Apr 21, 1993AB1RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Watson LabsAFEDITAB CRnifedipineTABLET, EXTENDED RELEASE;ORAL075659-001Oct 26, 2001AB1RXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Osmotica Pharm UsNIFEDIPINEnifedipineTABLET, EXTENDED RELEASE;ORAL077127-002Nov 21, 2005AB2RXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
PfizerPROCARDIAnifedipineCAPSULE;ORAL018482-001Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Osmotica Pharm UsNIFEDIPINEnifedipineTABLET, EXTENDED RELEASE;ORAL077127-001Nov 21, 2005AB2RXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Martec Usa LlcNIFEDIPINEnifedipineTABLET, EXTENDED RELEASE;ORAL075414-003Mar 23, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Osmotica Pharm UsNIFEDIPINEnifedipineTABLET, EXTENDED RELEASE;ORAL077410-001Oct 3, 2007AB2RXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Valeant Pharms NorthNIFEDIPINEnifedipineTABLET, EXTENDED RELEASE;ORAL075269-002Dec 4, 2000AB1RXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Actavis ElizabethNIFEDIPINEnifedipineCAPSULE;ORAL072579-001Jan 8, 1991ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: nifedipine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
PfizerPROCARDIA XLnifedipineTABLET, EXTENDED RELEASE;ORAL019684-001Sep 6, 1989► Subscribe► Subscribe
PfizerPROCARDIA XLnifedipineTABLET, EXTENDED RELEASE;ORAL019684-001Sep 6, 1989► Subscribe► Subscribe
PfizerPROCARDIAnifedipineCAPSULE;ORAL018482-002Jul 24, 1986► Subscribe► Subscribe
PfizerPROCARDIA XLnifedipineTABLET, EXTENDED RELEASE;ORAL019684-002Sep 6, 1989► Subscribe► Subscribe
PfizerPROCARDIA XLnifedipineTABLET, EXTENDED RELEASE;ORAL019684-001Sep 6, 1989► Subscribe► Subscribe
AlvogenADALAT CCnifedipineTABLET, EXTENDED RELEASE;ORAL020198-002Apr 21, 1993► Subscribe► Subscribe
Bayer PharmsADALATnifedipineCAPSULE;ORAL019478-001Nov 27, 1985► Subscribe► Subscribe
PfizerPROCARDIA XLnifedipineTABLET, EXTENDED RELEASE;ORAL019684-002Sep 6, 1989► Subscribe► Subscribe
PfizerPROCARDIA XLnifedipineTABLET, EXTENDED RELEASE;ORAL019684-003Sep 6, 1989► Subscribe► Subscribe
PfizerPROCARDIAnifedipineCAPSULE;ORAL018482-002Jul 24, 1986► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
US Department of Justice
Teva
Fuji
Deloitte
Novartis
Accenture
Cerilliant
Medtronic
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot